Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029870

Enrollment

Unknown

Registered

2020-02-15

Start date

2020-02-15

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Nucleic acid detection method of novel Coronavirus pneumonia

Index test:IgM/IgG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Confirmed and suspected cases of novel Coronavirus pneumonia

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Positive/Negtive;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactCao Jun

Jiangsu Institute of Parasitic Diseases

caojuncn@hotmail.com+86 0510-68781007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026